These new studies, involving a total of 18 patients, confirmed that teclistamab holds substantial promise as an off-the-shelf ...
Boehringer Ingelheim is advancing biomarker-informed approaches and extending precision care across multiple cancers and stages of disease, reinforcing its ambition to bring unprecedented impact and ...
A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with ...
Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.
Treatment with teplizumab significantly slowed the decrease in mean C-peptide levels, a marker of beta cell function, compared with placebo. The Food and Drug Administration (FDA) has granted ...
Formulas are powerful tools for performing calculations and analyzing data in Excel. In this beginner’s guide, you’ll learn how to use formulas (with or without help from the Copilot AI assistant) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results